Category

• Pipeline2

Organizations

• Bausch + Lomb64
• Alcon, Inc.43
• Eyes On Eyecare43
• American Optometric Association34
• Harrow28
• Glaukos26
• Regeneron22
• Topcon Healthcare22
• Aldeyra Therapeutics20
• Sight Sciences19

Tags

• FDA1
• Clinical Trials1
• Dry Eye1
• Dry Eye Disease1
• Neurotrophic Keratitis1

• Organizations: BRIM Biotechnology✕

Clear all

Pipeline

BRIM Biotechnology submits IND for neurotrophic keratitis study

Company is seeking to initiate a phase 2 study of BRIM424 in Q2 2023.

Pipeline

BRIM Biotechnology enrolls first patient in DES trial

Phase 3 clinical trial is evaluating BRM412, an investigational candidate based on a neurotrophic stem cell regenerative peptide (PDSP), for the treatment of dry eye syndrome.